Results 1 to 10 of about 55,552 (271)

Drug eluting stents [PDF]

BMJ, 2006
Last week an expert panel of the US Food and Drug Administration (FDA) recommended that the FDA should issue warnings to doctors and patients about drug eluting coronary stents. The safety of such stents is unclear except in low risk patients. Furthermore, patients with drug eluting stents should take antiplatelet therapy for at least one year after ...
Gershlick, AH, Richardson, G
  +10 more sources

Drug-eluting stents [PDF]

Canadian Medical Association Journal, 2007
In their recent systematic review, Suzanne Ligthart and associates compared analyses of the cost-effectiveness of drug-eluting stents.[1][1] They found that in most studies in which an incremental cost-effectiveness ratio greater than $50 000 per quality-adjusted life-year was calculated the ...
E Liana, Falcone, Navdeep, Tangri
  +8 more sources

Impact of alirocumab on neoatherosclerosis formation and vessel healing after drug-eluting stent implantation in patients with acute myocardial infarction: a substudy of the PACMAN-AMI trial. [PDF]

Int J Cardiovasc Imaging
Kakizaki R, Ueki Y, Koskinas KC, Shibutani H, Losdat S, Biccirè FG, Otsuka T, Häner JD, Lønborg J, Kaiser C, Iglesias JF, Ondracek AS, Spirk D, Siontis GCM, Daemen J, Engstrøm T, Lang IM, Räber L.   +17 more
europepmc   +3 more sources

RETRACTION: Comparison of Clinical Outcomes Between Intravascular Ultrasound-Guided and Angiography-Guided Drug-Eluting Stent Implantation: A Meta-Analysis of Randomised Control Trials and Systematic Review. [PDF]

Int Wound J
europepmc   +3 more sources

Aneurysmal degeneration of fluoropolymer-coated paclitaxel-eluting stent in the superficial femoral artery: a rising concern

CVIR Endovascular, 2021
Background Although several clinical reports demonstrated a durable patency rate after a novel fluoropolymer-coated paclitaxel-eluting stent (Eluvia; Boston Scientific, Marlborough, MA, USA) placement, aneurysmal degeneration after drug-eluting stent ...
Takuya Tsujimura, Osamu Iida, Mitsutoshi Asai, Masaharu Masuda, Shin Okamoto, Takayuki Ishihara, Kiyonori Nanto, Takashi Kanda, Yasuhiro Matsuda, Yosuke Hata, Hiroyuki Uematsu, Taku Toyoshima, Naoko Higashino, Toshiaki Mano   +13 more
doaj   +1 more source

Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer‐Generation Drug‐Eluting Stents

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Percutaneous coronary intervention of calcified lesions was associated with worse outcomes in the era of bare‐metal and first‐generation drug‐eluting stents. Data on percutaneous coronary intervention of calcified lesions with newer‐generation
Rayyan Hemetsberger, Mohammad Abdelghani, Ralph Toelg, Nader Mankerious, Abdelhakim Allali, Hector M. Garcia‐Garcia, Stephan Windecker, Thierry Lefèvre, Shigeru Saito, Ton Slagboom, David Kandzari, Jacques Koolen, Ron Waksman, Gert Richardt   +13 more
doaj   +1 more source

Drug-eluting stent thrombosis [PDF]

Therapeutic Advances in Cardiovascular Disease, 2009
Stent thrombosis is a rare complication following stent implantation; if it occurs, however, it is associated with a high morbidity and mortality. Despite reduced rates of restenosis, drug-eluting stents (DES) have not reduced the incidence of stent thrombosis as compared with bare-metal stents (BMS).
Stähli, B E, Camici, G G, Tanner, F C
openaire   +3 more sources

Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated With Percutaneous Coronary Intervention: The Scandinavian Organization for Randomized Trials With Clinical Outcome IV (SORT OUT IV) [PDF]

, 2012
BACKGROUND: Among drug-eluting stents released to date, the sirolimus-eluting stent has demonstrated the least amount of late lumen loss, but its efficacy and safety have not been compared head-to-head with the next-generation everolimus-eluting stent ...
Aarøe, Jens, Boel Villadsen, Anton, Bøtker, Hans Erik, Christiansen, Evald Høj, Hansen, Hans-Henrik Tilsted, Hansen, Henrik Steen, Junker, Anders, Kaltoft, Anne, Kristensen, Steen Dalby, Krusell, Lars Romer, Lassen, Jens Flensted, Madsen, Morten, Maeng, Michael, Nørregaard Hansen, Knud, Okkels Jensen, Lisette, Pedersen, Knud Erik, Ravkilde, Jan, Sanchez, Richardo, Sørensen, Henrik Toft, Thayssen, Per, Thuesen, Leif   +20 more
core   +1 more source

Progress in treatment by percutaneous coronary intervention: The stent of the future [PDF]

, 2013
First generation drug-eluting stents have considerably reduced in-stent restenosis and broadened the applications of percutaneous coronary interventions for the treatment of coronary artery disease.
Bourantas, C.V. (Christos), Diletti, R. (Roberto), Farooq, V. (Vasim), Garcia-Garcia, H.M. (Hector), Garg, S.A. (Scot), Gogas, B.D. (Bill), Kharlamov, A.N. (Alexander ), Muramatsu, T. (Takashi), Onuma, Y. (Yoshinobu), Ozaki, Y. (Yukio), Serruys, P.W.J.C. (Patrick), Zhang, Y. (Yaojun)   +11 more
core   +3 more sources

A polymer coated cicaprost-eluting stent increases neointima formation and impairs vessel function in the rabbit iliac artery [PDF]

, 2016
Drug-eluting stents have been successful in reducing in-stent restenosis but are not suitable for all lesion types and have been implicated in causing late stent thrombosis due to incomplete regeneration of the endothelial cell layer.
Jones, Robert L., Kennedy, Simon, McCormick, Christopher, Mullen, Alexander B., Wadsworth, Roger M.   +4 more
core   +2 more sources